$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

초록
AI-Helper 아이콘AI-Helper

목적: (R)-1-(2-Chlorophenyl)-N-methyl-N-1-(1-methyl-propyl)-3-isoquinoline carboxamide ((R)-PK11195)는 말초형 벤조디아제핀 수용체 (PBR)의 친화성이 높으며, 활성화된 소교세포(microglia)의 PBR에 선택적으로 결합하는 것으로 알려져 있다. 본 연구에서는 말초형 벤조디아제핀 수용체 (PBR)의 FET용 리간드인[$^{11}$C](R)-PK11195를, 절차가 빠르고 간단한 [$^{11}$C]CH$_3$I 자동합성장치 및 루프법을 도입해서 합성하였다. 대상 및 방법: 사이클로트론에서 $^{14}$N(p,a)$^{11}$C핵반응에 의하여 생산된 [$^{11}$C]Co$_2$를 0.2 M LiAlH$_4$/THF (0.2 mL)로 환원한 다음 HI (1 mL)과 반응하여 [$^{11}$C]CH$_3$I를 생산하였다. 반응용매인 NaH DMF complex (0.1 mL)와 녹인 전구물질 (R)-N-desmethyl-PK11195 (1 mg)을 녹인 DMSO (0.1mL)를 섞은 혼합액을 HPLC의 루프에 미리 주입하고 [$^{11}$C]CH$_3$I를 상온에서 5분 동안 질소가스로 불어준 뒤에 semi-preparative HPLC로 [$^{11}$C](R)-PK11195를 분리하였다. 결과: 전구물질과 [$^{11}$C]CH$_3$I의 [$^{11}$C]메틸화 반응에서의 표지효율은 71.8$\pm$8.5% 이었다. 분리 후 얻은 [$^{11}$C](R)-PK11195의 비방사능은 11.8$\pm$6.4 GBq/$\mu$mol이었으며, 방사화학적 순도는 99.2% 이상이었다. C-11 표지 후 얻어진 (R)-PK11195의 물질의 질량 분석은 m/z 353.1 (M+1)으로 물질구조를 확인 할 수 이었다. 결론: 뇌염증에 의한 활성화 소교세포의 영상화를 위한 PET용 방사성의약품인 [$^{11}$C](R)-PK11195를 반복적으로 생산해야 하는 임상 적용을 위해, 합성절차가 빠르고 간단한 [$^{11}$C]CH$_3$I 자동화 합성장치를 1차 루프 방법을 이용하여 $^{11}$C을 표지 할 수 있었다. 이 연구를 통해서 [$^{11}$C](R)PK11195 표지 할 때 반응 단계를 줄이고 반응을 실온에서 할 수 있어서 표지과정을 보다 단순화할 수 있었으며, NaH의 DMF현탁액을 사용함으로써 보다 안전하게 생산할 수 있게 되었다.

Abstract AI-Helper 아이콘AI-Helper

Purpose: ((R)-1-(2-chlorophenyl)-N-1-[$^{11}$C]methyl-N(1-propyl)-3-isoquinoline carboxamide ((R)-PK11195) is a specific ligand for the peripheral type benzodiazepine receptor and a marker of activated microglia, used to measure inflammation in neurologic disorders. We report here that a ...

주제어

AI 본문요약
AI-Helper 아이콘 AI-Helper

* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.

문제 정의

  • 이 연구에서는 [須C](R)-PK11195를 임상에 적용하기 위해 합성절차가 간단하고 빠른 [打胡(3氏1자동화 합성장치를이용한 1차 루프 방법으로 조제하고자 한다. (Fig.
본문요약 정보가 도움이 되었나요?

참고문헌 (50)

  1. Gerhard A, Pavese N, Hotton G, Turkheimer F, Es M, Hammers A, et al. In vivo imaging of microglial activation with [ $^{11}$ C](R)PK11195 PET in idiopathic Parkinson's disease. Neurobiol Dis 2006;21:404-12 

  2. Tai YF, Pavese N, Gerhard A, Tabrizi SJ, Barker RA, Brooks DJ, et al. Imaging microglial activation in Huntington's disease. Brain Res Bull 2007;72:148-51 

  3. Shah F, Hume SP, Pike VW, Ashworth S, McDermott J. Synthesis of the enantiomers of [N-methyl- $^{11}$ C]PK11195 and comparison of their behaviours as radioligands for PK binding sites in rats. Nucl Med Biol 1994;21:573-81 

  4. Banati RB, Graeber MB. Surveillance, intervention and cytotoxicity: is there a protective role of microglia? Dev Neurosci 1994;16:114-27 

  5. Schwartz M. Macrophages and microglia in central nervous system injury: are they helpful or harmful? J Cereb Blood Flow Metab 2003;23:385-94 

  6. Kremlev SG, Roberts RL, Palmer C. Differential expression of chemokines and chemokine receptors during microglial activation and inhibition. J Neroimmunol 2004;149:1-9 

  7. Chao CC, Hu S, Peterson PK. Modulation of human microglial cell superoxide production by cytokines. J Leukoc Biol 1995;58:65-70 

  8. Kim SU, de Vellis J. Microglia in health and disease. J Neurosci Res 2005;81:302-13 

  9. Wang X, Chen S, Ma G, Ye M, Lu G. Involvement of proinflammatory factors, apoptosis, caspase-3 activation and Ca2+ disturbance in microglia activation-mediated dopaminergic cell degeneration. Mech Ageing Dev 2005;126:1241-54 

  10. McGeer EG, McGeer PL. The importance of inflammatory mechanisms in Alzheimer disease. Exp Gerontol 1998;33:371-8 

  11. McGeer PL, McGeer EG. Inflammation and neurodegeneration in Parkinson's disease. Parkinsonism Relat Disord 2004;10(Suppl 1):S3-S7 

  12. Sapp E, Kegel KB, Aronin N, Hashikawa T, Uchiyama Y, Tohyama K, et al. Early and progressive acclUl1ulation of reactive microglia in the Huntington disease brain. J Neuropathol Exp Neurol 2001;60:161-72 

  13. Sargsyan SA, Monk PN, Shaw PJ. Microglia as potential contributors to motor neuron injury in amyotrophic lateral sclerosis. Glia 2005;51:241-53 

  14. Koh S. Microglial Imaging in neurological disorders with PK11195 PET. J Korean Soc Clin Neurophysiol 2007;9:91-7 

  15. Parola AL, Yamamura HI, Laird HE. Peripheral-type benzodiazepine receptors. Life Sci 1993;52:1329-42 

  16. Gerhard A, Trender-Gerhard I, Turkheimer F, Quinn NP, Bhatia KP, Brooks DJ. In vivo imaging of microglial activation with [ $^{11}$ C](R)-PK11195 PET in progressive supranuclear palsy. Mov Disord 2006;21:89-93 

  17. Cagnin A, Brooks DJ, Kennedy AM, Gunn RN, Myers R, Turkheimer FE, et al. In-vivo measurement of activated microglia in dementia. Lancet 2001;358:461-7 

  18. Gerhard A, Banati RB, Goerres GB, Cagnin A, Myers R, Gunn RN, et al. [ $^{11}$ C](R)-PK11195 PET imaging of microglial activation in multiple system atrophy. Neurology 2003;61:686-9 

  19. Gerhard A, Watts J, Trender-Gerhard I, Turkheimer F, Banati RB, Bhatia K, et al. In vivo imaging of microglial activation with [ $^{11}$ C](R)-PK11195 PET in corticobasal degeneration. Mov Disord 2004;19:1221-6 

  20. Groom GN, Junck L, Foster NL, Frey KA, Kuhl DE. PET of peripheral benzodiazepine binding sites in the microgliosis of Alzheimer's disease. J Nucl Med 1995;36:2207-10 

  21. Henkel K, Karitzky J, Schmid M, Mader I, Glatting G, Unger JW, et al. Imaging of activated microglia with PET and [ $^{11}$ C]PK11195 in corticobasal degeneration. Mov Disord 2004;19:817-21 

  22. Pavese N, Gerhard A, Tai YF, Ho AK, Turkheimer F, Barker RA, et al. Microglial activation correlates with severity in Huntington disease: a clinical and PET study. Neurology 2006;66:1638-43 

  23. Tai YF, Pavese N, Gerhard A, Tabrizi SJ, Barker RA, Brooks DJ, et al. Microglial activation in presymptomatic Huntington's disease gene carriers. Brain 2007;130:1759-66 

  24. Turner MR, Cagnin A, Turkheimer FE, Miller CC, Shaw CE, Brooks DJ, et al. Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [ $^{11}$ C](R)-PK11195 positron emission tomography study. Neurobiol Dis 2004;15:601-9 

  25. Rao VL, Bowen KK, Rao AM, Dempsey RJ. Up-regulation of the peripheral-type benzodiazepine receptor expression and [ $^{3}$ H$ ]PK11195 binding in gerbil hippocampus after transient forebrain ischemia. J Neurosci Res 2001;64:493-500 

  26. Hammoud DA, Endres CJ, Chander AR, Guilarte TR, Wong DF, Sacktor NC, et al. Imaging glial cell activation with [ $^{11}$ C]-RPK11195 in patients with AIDS. J Neurovirol 2005;11:346-55 

  27. Mankowski JL, Queen SE, Tarwater PJ, Adams RJ, Guilarte TR. Elevated peripheral benzodiazepine receptor expression in simian immunodeficiency virus encephalitis. J Neurovirol 2003;9:94-100 

  28. Vowinckel E, Reutens D, Becher B, Verge G, Evans A, Owens T, et al. PK11195 binding to the peripheral benzodiazepine receptor as a marker of microglia activation in multiple sclerosis and experimental autoimmune encephalomyelitis. J Neurosci Res 1997;50:345-53 

  29. Versijpt J, Debruyne JC, Van Laere KJ, De Vos F, Keppens J, Strijckmans K, et al. Microglial imaging with positron emission tomography and atrophy measurements with magnetic resonance imaging in multiple sclerosis: a correlative study. Mult Scler 2005;11:127-34 

  30. Debruyne JC, Versijpt J, Van Laere KJ, De Vos F, Keppens J, Strijckmans K, et al. PET visualization of microglia in multiple sclerosis patients using [ $^{11}$ C]PK11195. Eur J Neurol 2003;10:257-64 

  31. Debruyne JC, Van Laere KJ, Versijpt J, De Vos F, Keppen J, Strijckmans K, et al. Semiquantification of the peripheral-type benzodiazepine ligand [[ $^{11}$ C]PK11195 in normal human brain and application in multiple sclerosis patients. Acta Neurol Belg 2002;102:127-35 

  32. Chen MK, Guilarte TR. Imaging the peripheral benzodiazepine receptor response in central nervous system demyelination and remyelination. Toxicol Sci 2006;91:532-9 

  33. Cagnin A, Gerhard A, Banati RB. The concept of in vivo imaging of neuroinflammation with [[ $^{11}$ C](R}-PK11195 PET. Ernst Schering Res Found Workshop 2002:179-91 

  34. Banati RE, Newcombe J, Gunn RN, Cagnin A, Turkheimer F, Heppner F, et al. The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. Brain 2000;123:2321-37 

  35. Gerhard A, Neumaier B, Elitok E, Glatting G, Ries V, Tomczak R, et al. In vivo imaging of activated microglia using [ $^{11}$ C]PK11195 and positron emission tomography in patients after ischemic stroke. Neuroreport 2000;11:2957-60 

  36. Gerhard A, Schwarz J, Myers R, Wise R, Banati RB. Evolution of microglial activation in patients after ischemic stroke: a [ $^{11}C$ ](R)-PK11195 PET study. Neuroimage 2005;24:591-5 

  37. Imaizumi M, Kim HJ, Zoghbi SS, Briard E, Hong J, Musachio JL, et al. PET imaging with [ $^{11}$ C]PBR28 can localize and quantify upregulated peripheral benzodiazepine receptors associated with cerebral ischemia in rat. Neurosci Lett 2007;411:200-5 

  38. Pappata S, Levasseur M, Gunn RN, Myers R, Crouzel C, Syrota A, et al. Thalamic microglial activation in ischemic stroke detected in vivo by PET and [ $^{11}$ C]PK11195. Neurology 2000;55:1052-4 

  39. Vowinckel E, Reutens D, Becher B, Verge G, Evans A, Owens T, et al. PKI1195 binding to the peripheral benzodiazepine receptor as a marker of microglia activation in multiple sclerosis and experimental autoimmune encephalomyelitis. J Neurosci Res 1997;50:345-53 

  40. Carnsonne R, Crouzel C, Comar D, Maziere M, Prenant C, Sastre J, et al. Synthesis of N-( $^{11}$ C) methyl, N-(methyl-1 propyl), (chloro-2 phenyl)-1 isoquinoleine carboxamide-3 (PK 11195): A new ligand for peripheral benzodiazepine receptors. J Label Compd Radiopharm 1984;21:985-91 

  41. Cremer JE, Hume SP, Cullen BM, Myers R, Manjil LG, Turton DR, et al. The distribution of radioactivity in brains of rats given [N-methyl- $^{11}$ C]PK 11195 in vivo after induction of a cortical ischaemic lesion. Int J Rad Appl Instrum B 1992;19:159-66 

  42. Hashimoto K, Inoue O, Suzuki K, Yamasaki T, Kojima M. Synthesis and evaluation of $^{11}$ C-PK 11195 for in vivo study of peripheral-type benzodiazepine receptors using positron emission tomography. Ann Nucl Med 1989;3:63-71 

  43. Choe YS. Radiolabeling methods used for preparation of molecular probes. Nucl Med Mol Imaging 2004;38:121-30 

  44. Larsen P, Ulin J, Dahlstrom K, Jensen M. Synthesis of [ $^{11}$ C]iodomethane by iodination of [ $^{11}$ C]methane. Appl Radiat Isot 1997;48:153-7 

  45. Crouzel C, Langstrom B, Pike VW, Coenen HH. Recommendations for a practical production of [ $^{11}$ C]methyl iodide. Appl Radiat Isot 1987;38:601-3 

  46. Rahman O, Kihlberg T, Langstrom B. Synthesis of N-methyl-N-(1-methylpropyl)-1-(2-chlorophenyl)isoquinoline-3-[ $^{11}$ C]carboxam ide ([ $^{11}$ C-carbonyl]PK11195) and some analognes using [ $^{11}$ C]carbon monoxide and 1-(2-chlorophenyl)isoquinolin-3-yl trifiate. J Am Chem Soc Perkin Trans 1 2002:2699-703 

  47. Wilson AA, Garcia A, Jin L, Houle S. Radiotracer synthesis from [ $^{11}$ C]-iodomethane: a remarkably simple captive solvent method. Nucl Med Biol 2000;27:529-32 

  48. Lee HJ, Jeong JM, Lee Y, Kim HW, Lee E, Lee DS, et al. Radiosynthesis of [ $^{11}$ C]6-OH-BTA-1 in different media and confirmation of reaction by-products. Nucl Med Mol Imaging 2007;41:241-6 

  49. Wilson AA, Garcia A, Chestakova A, Kung H, Houle S. A rapid one-step radiosynthesis of the ${\beta}$ -amyloid imaging radiotracer N-methyl-[ $^{11}$ C]2-(4'-methylaminophenyl)-6-ydroxybenzothiazole ([ $^{11}$ C]-6-OH-BTA-1). J Label Compd Radiopharm 2004;47:679-82 

  50. Bachman DL, Wolf PA, Linn R, Knoefel JE, Cobb J, Belanger A, et al. Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham Study. Neurology 1992;42:115-9 

저자의 다른 논문 :

LOADING...

관련 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로